Sex, the brain and hypertension: Brain oestrogen receptors and high blood pressure risk factors

Clinical Science

Volumn 130, Issue 1, 2016, Pages 9-18

  Hay, Meredith ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Blood pressure; Central nervous system; Oestrogen; PVN; RVLM; Sex; SFO

Indexed keywords

ESTROGEN RECEPTOR;

ADRENERGIC SYSTEM; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRAIN LEVEL; CARDIOVASCULAR RISK; HUMAN; HYPERTENSION; INFLAMMATION; OBESITY; PARAVENTRICULAR THALAMIC NUCLEUS; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; ROSTRAL VENTROLATERAL MEDULLA; SEX DIFFERENCE; STRESS; SUBFORNICAL ORGAN; SYMPATHETIC NERVE; AGE; ANIMAL; BRAIN; COMORBIDITY; FEMALE; HEALTH DISPARITY; MALE; MENTAL STRESS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR; SIGNAL TRANSDUCTION;

AGE FACTORS; ANIMALS; BLOOD PRESSURE; BRAIN; COMORBIDITY; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; INFLAMMATION; MALE; MIDDLE AGED; OBESITY; RECEPTORS, ESTROGEN; RISK FACTORS; SEX FACTORS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84951926159     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20150654     Document Type: Review

References (105)

1. Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K. and He, J. (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365, 217-223
2. Cutler, J.A., Sorlie, P.D., Wolz, M., Thom, T., Fields, L.E. and Roccella, E.J. (2008) Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension 52, 18-27
3. Yanes, L.L., Romero, D.G., Iliescu, R. and Reckelhoff, J.F. (2011) A single pill to treat postmenopausal hypertension? Not yet. Curr. Top. Med. Chem. 11, 1736-1741
4. Sandberg, K. and Ji, H. (2012) Sex differences in primary hypertension. Biol. Sex Differ. 3, 7
5. Maranon, R. and Reckelhoff, J.F. (2013) Sex and gender differences in control of blood pressure. Clin. Sci. (Lond.) 125, 311-318
6. Maric-Bilkan, C., Gilbert, E.L. and Ryan, M.J. (2014) Impact of ovarian function on cardiovascular health in women: focus on hypertension. Int. J. Women's Health 6, 131-139
7. Esler, M.D., Eikelis, N., Lambert, E. and Straznicky, N. (2008) Neural mechanisms and management of obesity-related hypertension. Curr. Cardiol. Rep. 10, 456-463
8. Lambert, E.A., Straznicky, N.E., Dixon, J.B. and Lambert, G.W. (2015) Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol. 309, H244-H258
9. Lambert, E.A., Rice, T., Eikelis, N., Straznicky, N.E., Lambert, G.W., Head, G.A., Hensman, C., Schlaich, M.P. and Dixon, J.B. (2014) Sympathetic activity and markers of cardiovascular risk in nondiabetic severely obese patients: the effect of the initial 10% weight loss. Am. J. Hypertens. 27, 1308-1315
10. Lambert, E., Straznicky, N., Eikelis, N., Esler, M., Dawood, T., Masuo, K., Schlaich, M. and Lambert, G. (2007) Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J. Hypertens. 25, 1411-1419
11. Kim, J.M., Kim, T.H., Lee, H.H., Lee, S.H. and Wang, T. (2014) Postmenopausal hypertension and sodium sensitivity. J. Menopausal Med. 20, 1-6
12. He, F.J., Li, J. and Macgregor, G.A. (2013) Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 346, f1325
13. Lima, R., Wofford, M. and Reckelhoff, J.F. (2012) Hypertension in postmenopausal women. Curr. Hypertens. Rep. 14, 254-260
14. Lambert, E.A. and Lambert, G.W. (2011) Stress and its role in sympathetic nervous system activation in hypertension and the metabolic syndrome. Curr. Hyperten. Rep. 13, 244-248
15. Esler, M., Eikelis, N., Schlaich, M., Lambert, G., Alvarenga, M., Dawood, T., Kaye, D., Barton, D., Pier, C and Guo, L. (2008) Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clin. Exp. Pharmacol. Physiol. 35, 498-502
16. Harrison, D.G., Guzik, T.J., Lob, H.E., Madhur, M.S., Marvar, P.J., Thabet, S.R., Vinh, A. and Weyand, C.M. (2011) Inflammation, immunity, and hypertension. Hypertension 57, 132-140
17. Xue, B., Johnson, A.K. and Hay, M. (2013) Sex differences in angiotensin II-and aldosterone-induced hypertension: the central protective effects of estrogen. Am. J. Physiol. Regul. Integr. Comp. Physiol. 305, R459-R463
18. Seals, D.R. (1989) Sympathetic neural discharge and vascular resistance during exercise in humans. J. Appl. Physiol. 66, 2472-2478
19. Charkoudian, N., Joyner, M.J., Johnson, C.P., Eisenach, J.H., Dietz, N.M. and Wallin, B.G. (2005) Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J. Physiol. 568 Pt 1, 315-321
20. Hart, E.C., Charkoudian, N., Wallin, B.G., Curry, T.B., Eisenach, J.H. and Joyner, M.J. (2009) Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 53, 571-576
21. Hart, E.C. and Charkoudian, N. (2014) Sympathetic neural regulation of blood pressure: influences of sex and aging. Physiology 29, 8-15
22. Joyner, M.J., Wallin, B.G. and Charkoudian, N. (2015) Sex differences and blood pressure regulation in humans. Exp. Physiol. doi: 10.1113/EP085146
23. Hart, E.C. and Charkoudian, N. (2011) Sympathetic neural mechanisms in human blood pressure regulation. Curr. Hypertens. Rep. 13, 237-243
24. Hart, E.C., Joyner, M.J., Wallin, B.G. and Charkoudian, N. (2012) Sex, ageing and resting blood pressure: gaining insights from the integrated balance of neural and haemodynamic factors. J. Physiol. 590 Pt 9, 2069-2079
25. Narkiewicz, K., Phillips, B.G., Kato, M., Hering, D., Bieniaszewski, L. and Somers, V.K. (2005) Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45, 522-525
26. Credeur, D.P., Holwerda, S.W., Boyle, L.J., Vianna, L.C., Jensen, A.K. and Fadel, P.J. (2014) Effect of aging on carotid baroreflex control of blood pressure and leg vascular conductance in women. Am. J. Physiol. Heart Circ. Physiol. 306, H1417-H425
27. Brito, M.B., Nobre, F. and Vieira, C.S. (2011) Hormonal contraception and cardiovascular system. Arq. Bras. Cardiol. 96, e81-e89
28. Maguire, K. and Westhoff, C. (2011) The state of hormonal contraception today: established and emerging noncontraceptive health benefits. Am. J. Obstet. Gynecol. 205 (4 Suppl), S4-S8
29. Akkad, A.A., Halligan, A.W., Abrams, K. and al-Azzawi, F. (1997) Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet. Gynecol. 89, 97-103
30. Vongpatanasin, W., Tuncel, M., Mansour, Y., Arbique, D. and Victor, R.G. (2001) Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 103, 2903-2908
31. Cannoletta, M. and Cagnacci, A. (2014) Modification of blood pressure in postmenopausal women: role of hormone replacement therapy. Int. J. Women's Health 6, 745-757
32. Harvey, R.E., Hart, E.C., Charkoudian, N., Curry, T.B., Carter, J.R., Fu, Q., Minson, C.T., Joyner, M.J. and Barnes, J.N. (2015) Oral contraceptive use, muscle sympathetic nerve activity, and systemic hemodynamics in young women. Hypertension 66, 590-597
33. Anderson, G.L., Limacher, M., Assaf, A.R., Bassford, T., Beresford, S.A., Black, H., Bonds, D., Brunner, R., Brzyski, R. and Caan, B. (2004) Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291, 1701-1712
34. Fung, M.M., Poddar, S., Bettencourt, R., Jassal, S.K. and Barrett-Connor, E. (2011) A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause 18, 629-637
35. Weitz, G., Elam, M., Born, J., Fehm, H.L. and Dodt, C. (2001) Postmenopausal estrogen administration suppresses muscle sympathetic nerve activity. J. Clin. Endocrinol. Metab. 86, 344-348
36. Xue, B., Badaue-Passos, D., Guo, F., Gomez-Sanchez, C.E., Hay, M. and Johnson, A.K. (2009) Sex differences and central protective effect of 17beta-estradiol in the development of aldosterone/NaCl-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 296, H1577-H1585
37. Xue, B., Pamidimukkala, J. and Hay, M. (2005) Sex differences in the development of angiotensin II-induced hypertension in conscious mice. Am. J. Physiol. Heart Circ. Physiol. 288, H2177-H2184
38. Xue, B., Pamidimukkala, J., Lubahn, D.B. and Hay, M. (2007) Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice. Am. J. Physiol. Heart Circ. Physiol. 292, H1770-H1776
39. Macefield, V.G. and Henderson, L.A. (2010) Real-time imaging of the medullary circuitry involved in the generation of spontaneous muscle sympathetic nerve activity in awake subjects. Hum. Brain Mapp. 31, 539-549
40. Henderson, L.A., Richard, C.A., Macey, P.M., Runquist, M.L., Yu, P.L., Galons, J.P. and Harper, R.M. (1985) Functional magnetic resonance signal changes in neural structures to baroreceptor reflex activation. J. Appl. Physiol. 96, 693-703
41. Lundblad, L.C., Fatouleh, R.H., McKenzie, D.K., Macefield, V.G. and Henderson, L.A. (2015) Brain stem activity changes associated with restored sympathetic drive following CPAP treatment in OSA subjects: a longitudinal investigation. J. Neurophysiol. 114, 893-901
42. Campos, R.R., Oliveira-Sales, E.B., Nishi, E.E., Paton, J.F. and Bergamaschi, C.T. (2015) Mechanisms of renal sympathetic activation in renovascular hypertension. Exp. Physiol. 100, 496-501
43. Barman, S.M. and Gebber, G.L. (2007) Role of ventrolateral medulla in generating the 10-Hz rhythm in sympathetic nerve discharge. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293, R223-R233
44. Spary, E.J., Maqbool, A. and Batten, T.F. (2009) Oestrogen receptors in the central nervous system and evidence for their role in the control of cardiovascular function. J. Chem. Neuroanat. 38, 185-196
45. Saleh, M.C., Connell, B.J. and Saleh, T.M. (2000) Autonomic and cardiovascular reflex responses to central estrogen injection in ovariectomized female rats. Brain Res 879, 105-114
46. Shih, C.D. (2009) Activation of estrogen receptor beta-dependent nitric oxide signaling mediates the hypotensive effects of estrogen in the rostral ventrolateral medulla of anesthetized rats. J. Biomed. Sci. 16, 60
47. Xue, B., Zhang, Z., Beltz, T.G., Johnson, R.F., Guo, F., Hay, M. and Johnson, A.K. (2013) Estrogen receptor-β in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats. Hypertension 61, 1255-1262
48. Pierce, J.P., Kievits, J., Graustein, B., Speth, R.C., Iadecola, C. and Milner, T.A. (2009) Sex differences in the subcellular distribution of angiotensin type 1 receptors and NADPH oxidase subunits in the dendrites of C1 neurons in the rat rostral ventrolateral medulla. Neuroscience 163, 329-338
49. Zimmerman, M.C., Lazartigues, E., Lang, J.A., Sinnayah, P., Ahmad, I.M., Spitz, D.R. and Davisson, R.L. (2002) Superoxide mediates the actions of angiotensin II in the central nervous system. Circ. Res. 91, 1038-1045
50. Van Kempen, T.A., Dodos, M., Woods, C., Marques-Lopes, J., Justice, N.J., Iadecola, C., Pickel, V.M., Glass, M.J. and Milner, T.A. (2015) Sex differences in NMDA GluN1 plasticity in rostral ventrolateral medulla neurons containing corticotropin-releasing factor type 1 receptor following slow-pressor angiotensin II hypertension. Neuroscience 307, 83-97
51. Ferguson, A.V. (2009) Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus. Neuroendocrinology 89, 370-376
52. Ciriello, J. (1997) Afferent renal inputs onto subfornical organ neurons responsive to angiotensin II. Am. J. Physiol. 272 5 Pt 2, R1684-R1689
53. Lob, H.E., Schultz, D., Marvar, P.J., Davisson, R.L. and Harrison, D.G. (2012) Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension 61, 382-37
54. Li, S., Case, A.J., Yang, R.F., Schultz, H.D. and Zimmerman, M.C. (2013) Over-expressed copper/zinc superoxide dismutase localizes to mitochondria in neurons inhibiting the angiotensin II-mediated increase in mitochondrial superoxide. Redox Biol 2, 8-14
55. 2+ influx in the subfornical organ. Am. J. Physiol. Heart Circ. Physiol. 305, H1451-H461
56. Xue, B., Zhao, Y., Johnson, A.K. and Hay, M. (2008) Central estrogen inhibition of angiotensin II-induced hypertension in male mice and the role of reactive oxygen species. Am. J. Physiol. Heart Circ. Physiol. 295, H1025-H1032
57. Rosas-Arellano, M.P., Solano-Flores, L.P. and Ciriello, J. (1999) Co-localization of estrogen and angiotensin receptors within subfornical organ neurons. Brain Res. 837, 254-262
58. Ciriello, J. and Roder, S. (2013) 17β-Estradiol alters the response of subfornical organ neurons that project to supraoptic nucleus to plasma angiotensin II and hypernatremia. Brain Res. 1526, 54-64
59. Xue, B., Zhang, Z., Beltz, T.G., Guo, F., Hay, M. and Johnson, A.K. (2015) Genetic knockdown of estrogen receptor-alpha in the subfornical organ augments ANG II-induced hypertension in female mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308, R507-R516
60. Chung, W.C., Pak, T.R., Suzuki, S., Pouliot, W.A., Andersen, M.E. and Handa, R.J. (2007) Detection and localization of an estrogen receptor beta splice variant protein (ERbeta2) in the adult female rat forebrain and midbrain regions. J. Comp. Neurol. 505, 249-267
61. Bingham, B., Williamson, M. and Viau, V. (2006) Androgen and estrogen receptor-beta distribution within spinal-projecting and neurosecretory neurons in the paraventricular nucleus of the male rat. J. Comp. Neurol. 499, 911-923
62. Xue, B., Singh, M., Guo, F., Hay, M. and Johnson, A.K. (2009) Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 297, H1638-H1646
63. Marques-Lopes, J., Lynch, M.K., Van Kempen, T.A., Waters, E.M., Wang, G., Iadecola, C. et al. (2015) Female protection from slow-pressor effects of angiotensin II involves prevention of ROS production independent of NMDA receptor trafficking in hypothalamic neurons expressing angiotensin 1A receptors. Synapse 69, 148-165
64. Gingerich, S. and Krukoff, T.L. (2006) Estrogen in the paraventricular nucleus attenuates L-glutamate-induced increases in mean arterial pressure through estrogen receptor beta and NO. Hypertension 48, 1130-1136
65. Xue, B., Singh, M., Guo, F., Hay, M. and Johnson, A.K. (2009) Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 297, H1638-H1646
66. Alberti, K.G., Zimmet, P. and Shaw, J. (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet. Med. 23, 469-480
67. Malik, S., Wong, N.D., Franklin, S.S., Kamath, T.V., L'Italien, G.J., Pio, J.R. and Williams, G.R. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 110, 1245-1250
68. Ford, E.S. (2005) Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28, 2745-2749
69. Esler, M., Straznicky, N., Eikelis, N., Masuo, K., Lambert, G. and Lambert, E. (2006) Mechanisms of sympathetic activation in obesity-related hypertension. Hypertension 48, 787-796
70. Alvarez, G.E., Ballard, T.P., Beske, S.D. and Davy, K.P. (2004) Subcutaneous obesity is not associated with sympathetic neural activation. Am. J. Physiol. Heart Circ. Physiol. 287, H414-H418
71. Alvarez, G.E., Beske, S.D., Ballard, T.P. and Davy, K.P. (2002) Sympathetic neural activation in visceral obesity. Circulation 106, 2533-2536
72. Brooks, V.L., Shi, Z., Holwerda, S.W. and Fadel, P.J. (2015) Obesity-induced increases in sympathetic nerve activity: sex matters. Auton. Neurosci. 187, 18-26
73. Karastergiou, K., Smith, S.R., Greenberg, A.S. and Fried, S.K. (2012) Sex differences in human adipose tissues-the biology of pear shape. Biol. Sex Differ. 3, 13
74. Friedman, J.M. and Mantzoros, C.S. (2015) 20 years of leptin: from the discovery of the leptin gene to leptin in our therapeutic armamentarium. Metabolism 64, 1-4
75. Haynes, W.G. (2005) Role of leptin in obesity-related hypertension. Exp. Physiol. 90, 683-688
76. Shi, Z. and Brooks, V.L. (2015) Leptin differentially increases sympathetic nerve activity and its baroreflex regulation in female rats: role of oestrogen. J. Physiol. 593, 1633-1647
77. Wauman, J. and Tavernier, J. (2011) Leptin receptor signaling: pathways to leptin resistance. Front. Biosci. 16, 2771-2793
78. Young, C.N., Morgan, D.A., Butler, S.D., Mark, A.L. and Davisson, R.L. (2013) The brain subfornical organ mediates leptin-induced increases in renal sympathetic activity but not its metabolic effects. Hypertension 61, 737-744
79. Mark, A.L., Agassandian, K., Morgan, D.A., Liu, X., Cassell, M.D. and Rahmouni, K. (2009) Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension 53, 375-380
80. Wang, S.J., Li, X.F., Jiang, L.S. and Dai, L.Y. (2012) Estrogen stimulates leptin receptor expression in ATDC5 cells via the estrogen receptor and extracellular signal-regulated kinase pathways. J. Endocrinol. 213, 163-172
81. Strong, A.L., Ohlstein, J.F., Biagas, B.A., Rhodes, L.V., Pei, D.T., Tucker, H.A., Llamas, C., Bowles, A.C., Dutreil, M.F. and Zhang, S. (2015) Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res. 17, 112
82. Meli, R., Pacilio, M., Raso, G.M., Esposito, E., Coppola, A., Nasti, A., Di Carlo, C., Nappi, C. and Di Carlo, R. (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145, 3115-3121
83. Hering, D., Lachowska, K. and Schlaich, M. (2015) Role of the sympathetic nervous system in stress-mediated cardiovascular disease. Curr. Hypertens. Rep. 17, 594
84. Schiöler, L., Söderberg, M., Rosengren, A., Järvholm, B. and Torén, K. (2015) Psychosocial work environment and risk of ischemic stroke and coronary heart disease: a prospective longitudinal study of 75 236 construction workers. Scand. J. Work Environ. Health 41, 280-287
85. Aguilera, G. (1994) Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15, 321-350
86. Bardgett, M.E., Sharpe, A.L. and Toney, G.M. (2014) Activation of corticotropin-releasing factor receptors in the rostral ventrolateral medulla is required for glucose-induced sympathoexcitation. Am. J. Physiol. Endocrinol. Metab. 307, E944-E953
87. Milner, T.A., Reis, D.J., Pickel, V.M., Aicher, S.A. and Giuliano, R. (1993) Ultrastructural localization and afferent sources of corticotropin-releasing factor in the rat rostral ventrolateral medulla: implications for central cardiovascular regulation. J. Comp. Neurol. 333, 151-167
88. Lindheim, S.R., Legro, R.S., Bernstein, L., Stanczyk, F.Z., Vijod, M.A., Presser, S.C. and Lobo, R.A. (1992) Behavioral stress responses in premenopausal and postmenopausal women and the effects of estrogen. Am. J. Obstet. Gynecol. 167, 1831-1836
89. Lindheim, S.R., Legro, R.S., Morris, R.S., Wong, I.L., Tran, D.Q., Vijod, M.A., Stanczyk, F.Z. and Lobo, R.A. (1994) The effect of progestins on behavioral stress responses in postmenopausal women. J. Soc. Gynecol. Investig. 1, 79-83
90. Veldhuis, J.D., Sharma, A. and Roelfsema, F. (2013) Age-dependent and gender-dependent regulation of hypothalamic-adrenocorticotropic-adrenal axis. Endocrinol. Metab. Clin. North Am. 42, 201-225
91. Handa, R.J. and Weiser, M.J. (2014) Gonadal steroid hormones and the hypothalamo-pituitary-adrenal axis. Front. Neuroendocrinol. 35, 197-220
92. Weiser, M.J. and Handa, R.J. (2009) Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 159, 883-895
93. Figueiredo, H.F., Ulrich-Lai, Y.M., Choi, D.C. and Herman, J.P. (2007) Estrogen potentiates adrenocortical responses to stress in female rats. Am. J. Physiol. Endocrinol. Metab. 292, E1173-E1182
94. Babb, J.A., Masini, C.V., Day, H.E. and Campeau, S. (2013) Sex differences in activated corticotropin-releasing factor neurons within stress-related neurocircuitry and hypothalamic-pituitary-adrenocortical axis hormones following restraint in rats. Neuroscience 234, 40-52
95. Ochedalski, T., Subburaju, S., Wynn, P.C. and Aguilera, G. (2007) Interaction between oestrogen and oxytocin on hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 19, 189-197
96. Dayas, C.V., Xu, Y., Buller, K.M. and Day, T.A. (2000) Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways. J. Neuroendocrinol. 12, 784-794
97. Lee, S.K., Ryu, P.D. and Lee, S.Y. (2013) Estrogen replacement modulates voltage-gated potassium channels in rat presympathetic paraventricular nucleus neurons. BMC Neurosci 14, 134
98. Guzik, T.J., Hoch, N.E., Brown, K.A., McCann, L.A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C. and Harrison, D.G. (2007) Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J. Exp. Med. 204, 2449-2460
99. Mattson, D.L., Lund, H., Guo, C., Rudemiller, N., Geurts, A.M. and Jacob, H. (2013) Genetic mutation of recombination activating gene 1 in Dahl salt-sensitive rats attenuates hypertension and renal damage. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304, R407-R414
100. De Miguel, C., Guo, C., Lund, H., Feng, D. and Mattson, D.L. (2011) Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease. Am. J. Physiol. Renal Physiol. 300, F734-F742
101. Xiao, L., Kirabo, A., Wu, J., Saleh, M.A., Zhu, L., Wang, F., Takahashi, T., Loperena, R., Foss, J.D. and Mernaugh, R.L. (2015) Renal denervation prevents immune cell activation and renal inflammation in angiotensin II-induced hypertension. Circ. Res. 117, 547-557
102. Tipton, A.J., Baban, B. and Sullivan, J.C. (2012) Female spontaneously hypertensive rats have greater renal anti-inflammatory T lymphocyte infiltration than males. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303, R359-R367
103. Pollow, D.P., Uhrlaub, J., Romero-Aleshire, M.J., Sandberg, K., Nikolich-Zugich, J., Brooks, H.L. and Hay, M. (2014) Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 64, 384-390
104. Ji, H., Zheng, W., Li, X., Liu, J., Wu, X., Zhang, M.A., Umans, J.G., Hay, M., Speth, R.C., Dunn, S.E. et al. (2014) Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension 64, 573-582
105. Sandberg, K., Ji, H. and Hay, M. (2015) Sex-specific immune modulation of primary hypertension. Cell Immunol. 294, 95-101